Emergent Biosolutions Inc


EBS

Price

9.35


Change

0.45


High

10.7


Low

8.78


Avg Volume

1,552,337


PE Ratio

-2.09


52 Week High

44.04


52 Week Low

7.74



Profile

Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases, opioid overdoses, and provides medical devices for biodefense purposes. The company's gross revenue in 2018 was $782.4 million; gross income was $438.2 million; EBITDA was $170.5 million. Among the company's notable products are BioThrax , the only anthrax vaccine licensed by the U.S. Food and Drug Administration and Narcan for the emergency treatment of opioid overdose. The company also manufactures pharmaceuticals for infectious diseases like cholera and typhoid.


Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright Ā© 2020 Finaza.IO. All Rights Reserved.